This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malanchère-Brès, E.
Right arrow Articles by Michel, M.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malanchère-Brès, E.
Right arrow Articles by Michel, M.-L.

 Previous Article  |  Next Article 

Journal of Virology, July 2001, p. 6482-6491, Vol. 75, No. 14
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.14.6482-6491.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

CpG Oligodeoxynucleotides with Hepatitis B Surface Antigen (HBsAg) for Vaccination in HBsAg-Transgenic Mice

E. Malanchère-Brès,1 P. J. Payette,2 M. Mancini,1 P. Tiollais,1 H. L. Davis,2 and M.-L. Michel1,*

Unité de Recombinaison et Expression Génétique, INSERM U.163, Institut Pasteur, 75724 Paris Cédex 15, France,1 and Loeb Health Research Institute at the Ottawa Hospital, Ottawa, Ontario, Canada2

Received 19 December 2000/Accepted 24 April 2001

DNA motifs containing unmethylated CpG dinucleotides within the context of certain flanking sequences enhance both innate and antigen-specific immune responses, due in part to the enhanced production of Th1-type cytokines. Here we explored the ability of CpG-containing oligodeoxynucleotides combined with recombinant hepatitis B surface antigen (HBsAg) to induce Th1 responses in mice that are transgenic for this antigen and that represent a model for asymptomatic hepatitis B virus chronic carriers. This was compared to hepatitis B virus-specific DNA-mediated immunization, which we have previously shown to induce the clearance of the transgene expression product and the down-regulation of hepatitis B virus mRNA in this transgenic mouse lineage. In control nontransgenic C57BL/6 mice, three immunizations with HBsAg and CpG triggered the production of anti-HBs antibodies and of HBs-specific T cells that secrete gamma interferon but do not display any HBsAg-specific cytotoxic activity. In the HBsAg-transgenic mice, immunization with HBsAg and CpG oligodeoxynucleotides, but not with CpG alone, induced the clearance of HBsAg circulating in the sera, with a concomitant appearance of specific antibodies, and was able to regulate the hepatitis B virus mRNA constitutively expressed in the liver. Finally, adoptive transfer experiments with CD8+ T cells primed in C57BL/6 mice with HBsAg and CpG oligodeoxynucleotide-based immunization show that these cells were able to partially control transgene expression in the liver and to clear the HBsAg from the sera of recipient transgenic mice without an antibody requirement. CpG oligodeoxynucleotides motifs combined with HBsAg could therefore represent a potential therapeutic approach with which to treat chronically infected patients.

* Corresponding author. Mailing address: Unité de Recombinaison et Expression Génétique, INSERM U.163, Institut Pasteur, 28 rue du Docteur Roux, 75724 Paris Cédex 15, France. Phone: 33/1 45 68 88 49. Fax: 33/1 45 68 89 43. E-mail: maloum{at}pasteur.fr.

Journal of Virology, July 2001, p. 6482-6491, Vol. 75, No. 14
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.14.6482-6491.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Jeong, S.-H., Qiao, M., Nascimbeni, M., Hu, Z., Rehermann, B., Murthy, K., Liang, T. J. (2004). Immunization with Hepatitis C Virus-Like Particles Induces Humoral and Cellular Immune Responses in Nonhuman Primates. J. Virol. 78: 6995-7003 [Abstract] [Full Text]  
  • Loirat, D., Mancini-Bourgine, M., Abastado, J.-P., Michel, M.-L. (2003). HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection. Int Immunol 15: 1125-1136 [Abstract] [Full Text]  
  • Karayiannis, P. (2003). Hepatitis B virus: old, new and future approaches to antiviral treatment. J Antimicrob Chemother 51: 761-785 [Abstract] [Full Text]  
  • Pyles, R. B., Higgins, D., Chalk, C., Zalar, A., Eiden, J., Brown, C., Van Nest, G., Stanberry, L. R. (2002). Use of Immunostimulatory Sequence-Containing Oligonucleotides as Topical Therapy for Genital Herpes Simplex Virus Type 2 Infection. J. Virol. 76: 11387-11396 [Abstract] [Full Text]  
  • Olbrich, A. R. M., Schimmer, S., Heeg, K., Schepers, K., Schumacher, T. N. M., Dittmer, U. (2002). Effective Postexposure Treatment of Retrovirus-Induced Disease with Immunostimulatory DNA Containing CpG Motifs. J. Virol. 76: 11397-11404 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»